Evidence map›Paper›PMID 40770594›Full record

ArticleAddiction biology2025

Machine Learning Classification of Smoking Behaviours-From Social Environment to the Prefrontal Cortex.

Pablo Reinhardt, Norman Zacharias, Marinus Fislage, Justin Böhmer, Barbara Hollunder, Zala Reppmann, Anton Wiehe, Rebecca Rajwich, Nanne Dominick, Kerstin Ritter and 10 more

Abstract read
In one paragraph

Article in Addiction biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Pablo ReinhardtDepartment of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Norman ZachariasDepartment of Otolaryngology, Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0001-5794-5716
Marinus FislageDepartment of Anesthesiology and Intraoperative Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0001-9102-1373
Justin BöhmerDepartment of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0003-3448-144X
Barbara HollunderDepartment of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0003-0104-6927
Zala ReppmannDepartment of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Anton WiehePharmaimage Biomarker Solutions Inc., Cambridge, Massachusetts, USA.
Rebecca RajwichDepartment of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID 0009-0002-7554-7134
Nanne DominickDepartment of Anesthesiology and Intraoperative Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Kerstin RitterDepartment of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Malek BajboujDepartment of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Thomas WienkerDepartment of Molecular Human Genetics, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Jürgen GallinatDepartment of Psychiatry, University Hospital Hamburg, Hamburg, Germany.
Norbert ThüraufDepartment of Psychiatry and Psychotherapy, University Clinic, Friedrich-Alexander-University of Erlangen-Nuremberg, Erlangen, Germany.
Johannes KornhuberDepartment of Psychiatry and Psychotherapy, University Clinic, Friedrich-Alexander-University of Erlangen-Nuremberg, Erlangen, Germany.
Falk KieferDepartment of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.ORCID 0000-0001-7213-0398
Michael WagnerDepartment of Psychiatry, University Hospital Bonn, Bonn, Germany.
Oliver TüscherDepartment of Psychiatry, University Hospital Mainz, Mainz, Germany.
Henrik WalterDepartment of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Georg WintererDepartment of Anesthesiology and Intraoperative Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Funding

Deutsche Forschungsgemeinschaft 402170461Deutsche Forschungsgemeinschaft Wi1316/9-1
6 · The paper itself

Abstract

The pronounced heterogeneity in smoking trajectories-ranging from occasional or heavy use to successful quitting -highlights substantial interindividual variation within the smoking population. Machine learning is particularly well suited to capture these complex patterns that may be challenging for traditional inferential statistics to uncover. In this study, we applied machine learning to data from a population-based cohort to identify multimodal markers that distinguish smokers from never smokers at baseline and predict long-term cessation success at a 10-year follow-up. We employed 10 times repeated nested cross-validation (10 outer folds, 5 inner folds) to analyse baseline data (T1) from 707 smokers-including 222 heavy smokers (FTND ≥ 4)-and 864 never smokers for smoking status classification. At the 10-year follow-up (T2), we further classified 60 successful quitters (≥ 1 year abstinent) versus 81 non-quitters. Feature importance was assessed using averaged SHAP values derived from test set predictions. Classification models achieved the following performance, expressed by the area under the receiver operating characteristic curve (AUROC; mean ± SD): smokers versus never smokers, 0.85 ± 0.03; heavy smokers versus never smokers, 0.92 ± 0.03; and quitters versus non-quitters, 0.68 ± 0.13. SHAP analysis identified markers of frontal functioning, cognitive control and smoking behaviour within the social environment among the most influential predictors of both smoking status and cessation success. In conclusion, our machine learning analyses support a multifactorial model of smoking behaviour and cessation success, which may inform nuanced risk stratification to advance the development of personalized cessation strategies.

Indexed as

Machine LearningPrefrontal CortexSmokingSmoking CessationSocial EnvironmentAdultFemaleHumansMaleMiddle Agedclassificationprefrontal functiontobacco use behaviour

Identifiers

PMID40770594
PMCPMC12328245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.